Biomarin Pharmaceutical Inc

Ownership Transactions Reported by 23 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	0
Sells	7	-319 K	100%	$86.70	-$27.7 M
Net	-7	-319 K	-100%		-$27.7 M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Jean Jacques Bienaime	Director	$55.6 M	-$13.6 M	-19.7%	May 20, 2024
Henry J. Fuchs	President, Worldwide R&D	$16.5 M	-$4.1 M	-19.9%	Mar 15, 2024
Alexander Hardy	Chief Executive Officer, Director	$12.4 M			Mar 15, 2024
Richard A. Meier	Director	$9.23 M			Jun 3, 2024
Elaine J. Heron	Director	$7.47 M			Jun 3, 2024
Charles Greg Guyer	EVP, Chief Technical Officer	$6.11 M	-$500 K	-7.56%	May 3, 2024
Brian Mueller	EVP, Chief Financial Officer	$5.89 M	-$376 K	-6%	Jun 28, 2024
Jeffrey Robert Ajer	EVP, Chief Commercial Officer	$5.54 M	-$1.21 M	-18%	May 2, 2024
George Eric Davis	EVP, Chief Legal Officer	$4.23 M	-$7.67 M	-64.5%	May 28, 2024
D. E. I. Pyott	Director	$3.83 M			May 21, 2024
V. Bryan Lawlis	Director	$3.19 M			May 23, 2023
Robert J. Hombach	Director	$2.71 M			May 21, 2024
Dennis Slamon	Director	$2.62 M			Mar 18, 2024
Willard H. Dere	Director	$2.49 M			May 21, 2024
Elizabeth M. Anderson	Director	$2.14 M			May 21, 2024
Andrea Acosta	GVP, Chief Accounting Officer	$1.75 M			Apr 30, 2021
Maykin Ho	Director	$1.65 M			May 21, 2024
Cristin Hubbard	EVP, Chief Commercial Officer	$1.49 M			May 20, 2024
Mark J. Alles	Director	$1.45 M			May 23, 2023
Erin Burkhart	GVP, Chief Accounting Officer	$1.17 M	-$206 K	-15%	May 17, 2024
Athena Countouriotis	Director	$532 K			May 21, 2024
Mark J. Enyedy	Director	$532 K			May 21, 2024
Barbara W. Bodem	Director	$532 K			May 21, 2024

Insider	Class	Transaction	%	Value $	Price $	Shares	Shares Owned	Date	Ownership